The 20 references in paper U. Kharlamova V., O. Il’icheva E., У. Харламова В., О. Ильичева Е. (2010) “СОСТОЯНИЕ ЭНДОТЕЛИАЛЬНОЙ ФУНКЦИИ И СИСТЕМЫ ГЕМОСТАЗА У БОЛЬНЫХ НА ГЕМОДИАЛИЗЕ // STATE OF ENDOTHELIAL FUNCTION AND HEMOSTASIS SYSTEM IN PATIENTS ON HEMODIALYSIS” / spz:neicon:nefr:y:2010:i:4:p:48-52

1
Ильин АП, Богоявленский ВФ. Тромбофилия при ге­ модиализе у больных хронической почечной недостаточно­ стью и ее фраксинопрофилактика и терапия. Казань, 2001; 3-32
(check this in PDF content)
2
Cella G, Vertolli U, Naso A. et al. Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis. Thromb Res 1996; 81: 671- 677
(check this in PDF content)
3
Манухина ЕБ, Малышев ИЮ. Роль оксида азота в сер­ дечно-сосудистой патологии: взгляд патофизиолога. Росс кардиологичжурн 2000; (5): 55-63
(check this in PDF content)
4
Bostom A, Brosnan JT, Hall B. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclrrosis 1995; 116: 59-62
(check this in PDF content)
5
Suliman ME, Divino Filho JC, Barany P et al. Effects of high-dose folic acid and pyridoxine on plasma and erythrocite sulfur amino acids in hemodialisis patients. J Am Soc Nephrol 1999; 10: 1287-1296
(check this in PDF content)
6
Смирнов АВ, Есаян АМ, Каюков ИГ и др. Современ­ ные подходы к замедлению прогрессирования хроничес­ кой болезни почек. Нефрология 2004; (3): 89-99
(check this in PDF content)
7
Hoenicb NA. Platelet and leucocytes behaviour during haemodialysis. Contrib Nephrol 1999; 125; 120-132
(check this in PDF content)
8
Lang D, Kredan MB, Lang D, Moat SJ. et al. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: Role for superoxide anions. Arterioscler Thromb Vasc Biol 2000; 5: 257-261
(check this in PDF content)
9
Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ. еt al. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 2000; 102: 871-875
(check this in PDF content)
10
Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 1997; 12: 14-18
(check this in PDF content)
11
Kanani P, Sinkey C, Browning R. et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 1999; 100: 1161­ 1168
(check this in PDF content)
12
Tawakol A, Forgione M, Stuehlinger M. et al. Homocysteine impairs coronary microvascular dilator function in humans. JACC 2002; 40 (6): 1051-1058
(check this in PDF content)
13
Loscalo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996; 98 (1): 5-7
(check this in PDF content)
14
Tawakol A, Omland T, Gerhard M. et al. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependant vasodilatation in humans. Curculation 1997; 95: 1119-1121
(check this in PDF content)
15
Sagripanti A, Cupisti A, Baicchi U. et al. Plasma parameters of the protrombotic state in chronic uremia. Nephron 1993; 63: 273-278
(check this in PDF content)
16
Mayer E, Jacobsen D, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517-527
(check this in PDF content)
17
Stein J, Mc Bride P Hyperhomocysteinemia and atherosclerotic vascular disease. Arch Intern Med 1998; 158: 1301-1306
(check this in PDF content)
18
Bardic R, Rugerri ZM, Savion N et al. Platelet aggregation on extracellular matrix: effect of a recombination GPIb-binding fragment of von Willebrand factor. Thromb Haemos 1993; 70: 522-526
(check this in PDF content)
19
Blann AD. Von Willebrand factor and the endothelium in vascular disease. Brit J Biomed Sci 1993; 50: 124-134
(check this in PDF content)
20
Ruggery ZM, Ware J, Ginsberg D. Von Willebrand factor. Thrombosis and Haemorrhage 1994; 67: 305-329 Поступила в редакцию 22.09.2010 г. Принята в печать 17.11.2010 г.
(check this in PDF content)